Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Association between tobacco smoking and response to tumour necrosis factor α inhibitor treatment in psoriatic arthritis: results from the DANBIO registry.

Højgaard P, Glintborg B, Hetland ML, Hansen TH, Lage-Hansen PR, Petersen MH, Holland-Fischer M, Nilsson C, Loft AG, Andersen BN, Adelsten T, Jensen J, Omerovic E, Christensen R, Tarp U, Ostgård R, Dreyer L.

Ann Rheum Dis. 2014 Jul 25. pii: annrheumdis-2014-205389. doi: 10.1136/annrheumdis-2014-205389. [Epub ahead of print]

PMID:
25063827
[PubMed - as supplied by publisher]
2.

Anti-TNF treatment response in rheumatoid arthritis patients is associated with genetic variation in the NLRP3-inflammasome.

Sode J, Vogel U, Bank S, Andersen PS, Thomsen MK, Hetland ML, Locht H, Heegaard NH, Andersen V.

PLoS One. 2014 Jun 26;9(6):e100361. doi: 10.1371/journal.pone.0100361. eCollection 2014.

PMID:
24967817
[PubMed - in process]
Free PMC Article
3.

Decreases in diagnostic delay are supported by sensitivity analyses.

Sørensen J, Hetland ML.

Ann Rheum Dis. 2014 Jul;73(7):e45. doi: 10.1136/annrheumdis-2014-205590. Epub 2014 Apr 16. No abstract available.

PMID:
24739326
[PubMed - indexed for MEDLINE]
4.

Contact frequency, travel time, and travel costs for patients with rheumatoid arthritis.

Sørensen J, Linde L, Hetland ML.

Int J Rheumatol. 2014;2014:285951. doi: 10.1155/2014/285951. Epub 2014 Feb 17.

PMID:
24693288
[PubMed]
Free PMC Article
5.

Diagnostic delay in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: results from the Danish nationwide DANBIO registry.

Sørensen J, Hetland ML; on behalf of all departments of rheumatology in Denmark.

Ann Rheum Dis. 2014 Feb 17. doi: 10.1136/annrheumdis-2013-204867. [Epub ahead of print]

PMID:
24534758
[PubMed - as supplied by publisher]
6.

A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial.

Axelsen MB, Eshed I, Hørslev-Petersen K, Stengaard-Pedersen K, Hetland ML, Møller J, Junker P, Pødenphant J, Schlemmer A, Ellingsen T, Ahlquist P, Lindegaard H, Linauskas A, Dam MY, Hansen I, Horn HC, Ammitzbøll CG, Jørgensen A, Krintel SB, Raun J, Krogh NS, Johansen JS, Ostergaard M; OPERA study group.

Ann Rheum Dis. 2014 Jan 16. doi: 10.1136/annrheumdis-2013-204537. [Epub ahead of print]

PMID:
24412895
[PubMed - as supplied by publisher]
7.

Determining a magnetic resonance imaging inflammatory activity acceptable state without subsequent radiographic progression in rheumatoid arthritis: results from a followup MRI study of 254 patients in clinical remission or low disease activity.

Gandjbakhch F, Haavardsholm EA, Conaghan PG, Ejbjerg B, Foltz V, Brown AK, Døhn UM, Lassere M, Freeston JE, Olsen IC, Bøyesen P, Bird P, Fautrel B, Hetland ML, Emery P, Bourgeois P, Hørslev-Petersen K, Kvien TK, McQueen FM, Østergaard M.

J Rheumatol. 2014 Feb;41(2):398-406. doi: 10.3899/jrheum.131088. Epub 2013 Dec 15.

PMID:
24334647
[PubMed - in process]
8.

Differentiation between early rheumatoid arthritis patients and healthy persons by conventional and dynamic contrast-enhanced magnetic resonance imaging.

Axelsen MB, Ejbjerg BJ, Hetland ML, Skjødt H, Majgaard O, Lauridsen UB, Hørslev-Petersen K, Boesen M, Kubassova O, Bliddal H, Østergaard M.

Scand J Rheumatol. 2014;43(2):109-18. doi: 10.3109/03009742.2013.824022. Epub 2013 Nov 6.

PMID:
24191910
[PubMed - indexed for MEDLINE]
9.

Increased soluble programmed death-1 (sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis.

Greisen SR, Rasmussen TK, Stengaard-Pedersen K, Hetland ML, Hørslev-Petersen K, Hvid M, Deleuran B.

Scand J Rheumatol. 2014;43(2):101-8. doi: 10.3109/03009742.2013.823517. Epub 2013 Nov 1.

PMID:
24182347
[PubMed - indexed for MEDLINE]
10.

M-ficolin levels reflect disease activity and predict remission in early rheumatoid arthritis.

Ammitzbøll CG, Thiel S, Jensenius JC, Ellingsen T, Hørslev-Petersen K, Hetland ML, Junker P, Krogh NS, Østergaard M, Stengaard-Pedersen K.

Arthritis Rheum. 2013 Dec;65(12):3045-50. doi: 10.1002/art.38179.

PMID:
24022747
[PubMed - indexed for MEDLINE]
11.

Upregulated baseline plasma CCL19 and CCR7 cell-surface expression on monocytes in early rheumatoid arthritis normalized during treatment and CCL19 correlated with radiographic progression.

Ellingsen T, Hansen I, Thorsen J, Møller BK, Tarp U, Lottenburger T, Andersen LS, Skjødt H, Pedersen JK, Lauridsen UB, Svendsen A, Lindegaard H, Jacobsen S, Østergaard M, Vestergaard A, Jurik AG, Junker P, Christensen AF, Hetland ML, Hørslev-Petersen K, Stengaard-Pedersen K.

Scand J Rheumatol. 2014;43(2):91-100. doi: 10.3109/03009742.2013.803149. Epub 2013 Aug 28.

PMID:
23980529
[PubMed - indexed for MEDLINE]
12.

Identification of the tyrosine-protein phosphatase non-receptor type 2 as a rheumatoid arthritis susceptibility locus in europeans.

Cobb JE, Plant D, Flynn E, Tadjeddine M, Dieudé P, Cornélis F, Ärlestig L, Dahlqvist SR, Goulielmos G, Boumpas DT, Sidiropoulos P, Krintel SB, Ørnbjerg LM, Hetland ML, Klareskog L, Haeupl T, Filer A, Buckley CD, Raza K, Witte T, Schmidt RE, FitzGerald O, Veale D, Eyre S, Worthington J.

PLoS One. 2013 Jun 20;8(6):e66456. doi: 10.1371/journal.pone.0066456. Print 2013.

PMID:
23840476
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Gain in quality-adjusted life-years in patients with rheumatoid arthritis during 1 year of biological therapy: a prospective study in clinical practice.

Linde L, Sørensen J, Østergaard M, Hetland ML.

J Rheumatol. 2013 Sep;40(9):1479-86. doi: 10.3899/jrheum.121387. Epub 2013 Jul 1. Erratum in: J Rheumatol. 2013 Sep;40(9):1634. Merete, Lund Hetland [corrected to Hetland, Merete Lund].

PMID:
23818719
[PubMed - indexed for MEDLINE]
14.

Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial.

Jensen TW, Hansen MS, Hørslev-Petersen K, Hyldstrup L, Abrahamsen B, Langdahl B, Zerahn B, Pødenphant J, Stengaard-Petersen K, Junker P, Østergaard M, Lottenburger T, Ellingsen T, Andersen LS, Hansen I, Skjødt H, Pedersen JK, Lauridsen UB, Svendsen AJ, Tarp U, Lindegaard H, Jurik AG, Vestergaard A, Hetland ML; Cimestra study group.

Ann Rheum Dis. 2014 Jun;73(6):1123-9. doi: 10.1136/annrheumdis-2012-203171. Epub 2013 May 9.

PMID:
23661492
[PubMed - indexed for MEDLINE]
15.

Clinical response, drug survival, and predictors thereof among 548 patients with psoriatic arthritis who switched tumor necrosis factor α inhibitor therapy: results from the Danish Nationwide DANBIO Registry.

Glintborg B, Ostergaard M, Krogh NS, Andersen MD, Tarp U, Loft AG, Lindegaard HM, Holland-Fischer M, Nordin H, Jensen DV, Olsen CH, Hetland ML.

Arthritis Rheum. 2013 May;65(5):1213-23. doi: 10.1002/art.37876.

PMID:
23460467
[PubMed - indexed for MEDLINE]
Free Article
16.

The frequency of anti-infliximab antibodies in patients with rheumatoid arthritis treated in routine care and the associations with adverse drug reactions and treatment failure.

Krintel SB, Grunert VP, Hetland ML, Johansen JS, Rothfuss M, Palermo G, Essioux L, Klause U.

Rheumatology (Oxford). 2013 Jul;52(7):1245-53. doi: 10.1093/rheumatology/ket017. Epub 2013 Mar 4.

PMID:
23459699
[PubMed - indexed for MEDLINE]
17.

Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial.

Hørslev-Petersen K, Hetland ML, Junker P, Pødenphant J, Ellingsen T, Ahlquist P, Lindegaard H, Linauskas A, Schlemmer A, Dam MY, Hansen I, Horn HC, Ammitzbøll CG, Jørgensen A, Krintel SB, Raun J, Johansen JS, Østergaard M, Stengaard-Pedersen K; OPERA Study-Group.

Ann Rheum Dis. 2014 Apr;73(4):654-61. doi: 10.1136/annrheumdis-2012-202735. Epub 2013 Feb 23.

PMID:
23434570
[PubMed - indexed for MEDLINE]
18.

[DANBIO: Danish Rheumatology Database].

Hetland ML, Jensen DV, Tarp U.

Ugeskr Laeger. 2012 Oct 15;174(42):2520. Danish. No abstract available.

PMID:
23079423
[PubMed - indexed for MEDLINE]
19.

The CIMESTRA study: intra-articular glucocorticosteroids and synthetic DMARDs in a treat-to-target strategy in early rheumatoid arhtritis.

Hetland ML, Hørslev-Petersen K.

Clin Exp Rheumatol. 2012 Jul-Aug;30(4 Suppl 73):S44-9. Epub 2012 Oct 16.

PMID:
23079125
[PubMed - indexed for MEDLINE]
20.

Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides - a follow-up study from the DANBIO Registry.

Dreyer L, Mellemkjær L, Andersen AR, Bennett P, Poulsen UE, Juulsgaard Ellingsen T, Hansen TH, Jensen DV, Linde L, Lindegaard HM, Loft AG, Nordin H, Omerovic E, Rasmussen C, Schlemmer A, Tarp U, Hetland ML.

Ann Rheum Dis. 2013 Jan;72(1):79-82. doi: 10.1136/annrheumdis-2012-201969. Epub 2012 Sep 3.

PMID:
22945500
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk